Aclaris Therapeutics
ACRS
ACRS
128 hedge funds and large institutions have $1.04B invested in Aclaris Therapeutics in 2022 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 45 increasing their positions, 37 reducing their positions, and 11 closing their positions.
Holders
128
Holders Change
+1
Holders Change %
+0.79%
% of All Funds
2.07%
Holding in Top 10
6
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-33.33%
% of All Funds
0.1%
New
13
Increased
45
Reduced
37
Closed
11
Calls
$483K
Puts
$362K
Net Calls
+$121K
Net Calls Change
+$116K
Top Buyers
| 1 |
1
Wellington Management Group
Boston,
Massachusetts
|
$86.4M |
| 2 |
2
BlackRock
New York
|
$80.1M |
| 3 |
3
Vanguard Group
Malvern,
Pennsylvania
|
$49.2M |
| 4 |
4
Walleye Capital
New York
|
$6.6M |
| 5 |
5
HighTower Advisors
Chicago,
Illinois
|
$3.03M |
Top Sellers
| 1 |
BI
1
BVF Inc
San Francisco,
California
|
$51.6M |
| 2 |
CC
2
Commodore Capital
New York
|
$29.6M |
| 3 |
3
Holocene Advisors
New York
|
$26.2M |
| 4 |
4
Fidelity Investments
Boston,
Massachusetts
|
$12.2M |
| 5 |
ACM
5
Aisling Capital Management
New York
|
$6.84M |
